ZNF501
Zinc finger protein 501
Also known as: MGC21738, ZN501_HUMAN, ZNF52
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96CX3
- Gene
- ZNF501
- Ensembl
- ENSG00000186446
- Chromosome
- 3
- Canonical length
- 271 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Involved in Golgi organization. Located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
271 residues, UniProt reviewed canonical sequence.
>Q96CX3|ZNF501
1 MNSSQISLRM KHGRVNMQKK PSKCSECGKF FTQRSSLTQH QRIHRGEKPY VCSECGSCFR
61 KQSNLTQHLR IHTGEKPYKC NECEKAFQTK AILVQHLRIH TGEKPYKCNE CGKAFCQSPS
121 LIKHQRIHTG EKPYKCTECG KAFSQSICLT RHQRSHSGDK PFKCNECGKA FNQSACLMQH
181 QRIHSGEKPY TCTECGKAFT QNSSLVEHER THTGEKLYKC SECEKTFRKQ AHLSEHYRIH
241 TGEKPYECVG CGKSFRHSSA LLRHQRLHAG ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF501 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 2 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 2 nTPM
- cerebellum: 1.9 nTPM
- ovary: 1.9 nTPM
- colon: 1.8 nTPM
- retina: 1.8 nTPM
- testis: 1.8 nTPM
Single-cell type
- bergmann glia: 8.5 nCPM
- oligodendrocyte progenitor cells: 7.3 nCPM
- oligodendrocytes: 5.3 nCPM
- astrocytes: 4.8 nCPM
- microglia: 4 nCPM
- brain inhibitory neurons: 3.6 nCPM
Immune cell
- naive B-cell: 1 nTPM
- eosinophil: 0.9 nTPM
- MAIT T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.9 nTPM
- memory B-cell: 0.8 nTPM
- NK-cell: 0.8 nTPM
Brain region
- cerebellum: 3.1 nTPM
- basal ganglia: 2.6 nTPM
- thalamus: 2.5 nTPM
- midbrain: 2.4 nTPM
- spinal cord: 2.4 nTPM
- amygdala: 2.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.79
- gnomAD pLI
- 0.28
- gnomAD missense Z
- -0.53
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF501 as an antibody target. Whether an autoantibody or antibody against ZNF501 could matter depends on whether native ZNF501 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF501 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF501 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...